NCT01940692View on ClinicalTrials.gov

Topical and Intravenous Administration of TXA Are Equally Effective in DAA THA

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Osteoarthrosis
Interventions
DRUG

1.5g intravenous Exacyl

intravenous administration of 1.5g Exacyl preoperatively

DRUG

3.0g intra-articular Exacyl

3g Intra-articular Exacyl administration postoperatively

Trial Locations (1)

3600

Ziekenhuis Oost-Limburg, Genk

All Listed Sponsors
lead

Ziekenhuis Oost-Limburg

OTHER

NCT01940692 - Topical and Intravenous Administration of TXA Are Equally Effective in DAA THA | Biotech Hunter | Biotech Hunter